Dapagliflozin Prescribing at ROTHSCHILD HOUSE GROUP
Drugs used in diabetes | Endocrine System
Items (12m)
5,915
Total Quantity
149.4K
NHS Cost
£183.1K
vs National Avg
+372.4%
ROTHSCHILD HOUSE GROUP prescribed 5,915 items of Dapagliflozin over the last 12 months at a cost of £183,080 to the NHS. This is 372.4% above the national average prescribing rate. Dapagliflozin is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
410
Jun 2026
387
Jun 2026
465
Jun 2026
421
Jun 2026
447
Jun 2026
472
Jun 2026
459
Jun 2026
580
Jun 2026
577
Jun 2026
540
Jun 2026
582
Jun 2026
575
Prescribing Details
| Total Items | 5,915 |
|---|---|
| Total Quantity | 149,437 |
| Total NHS Cost | £183,080 |
| Presentations | 3 different forms |
| vs National Average | +372.4% |
Dapagliflozin Prescribing Comparison
| This practice | 5,915 items |
|---|---|
| National average per practice | 1,252 items |
| Difference | +372.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.